Search
News & Opinion
Magazine
Current Issue
Archives
Features
Infographics
Top 10 Innovations
Subjects
Cancer Biology
Careers
Cell & Molecular Biology
Clinical Research
Coronavirus
Disease & Medicine
Ecology & Environment
Evolution
Genetics & Genomics
History
Immunology
Microbiology
Neuroscience
Obituaries
Paleontology
Pharma & Biotech
Policy
Profile
Publishing
Research Integrity
Techniques
Multimedia
Infographics
Image of the Day
Crossword Puzzles
Videos
Research Resources
Webinars
The Scientist University
eBooks
Podcasts
Infographics
Videos
Subscribe
Home
Subjects
Tamiflu
Tamiflu
Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
Kerry Grens | Feb 25, 2018
One dose of the medication, called Xofluza, cripples influenza by interfering with an enzyme critical for viral replication.
Tamiflu Reviewed Again
Kerry Grens | Jan 30, 2015
The controversial antiviral drug earns better marks in the most recent analysis of the evidence.
Researchers Question Tamiflu Review
Tracy Vence | Apr 23, 2014
Critics claim updated analysis of antiviral medication was statistically weak and based on unreliable randomized clinical trial data.
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
Data Diving
Kerry Grens | May 1, 2012
What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.